List of works - Maria Teresa Cibeira

A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma.

scientific article

Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition

scientific article published on 01 October 2009

Acquired Fanconi syndrome secondary to monoclonal gammopathies: a case series from a single center

scientific article published on 15 June 2013

Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents

scientific article published on 4 January 2008

Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome.

scientific article published on 26 February 2018

Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis

scientific article published on 30 July 2020

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m

scientific article published on 23 August 2010

Bortezomib-induced severe hepatitis in multiple myeloma: a case report

scientific article

Bortezomib: an effective agent in extramedullary disease in multiple myeloma

scientific article published on 9 March 2006

Challenges in the Management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic

scientific article published on 01 June 2020

Dermatomyositis associated with acute myeloid leukaemia: a paraneoplastic association or a drug-induced phenomenon?

scientific article published on 01 January 2004

Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experience

scientific article

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression

scientific article published on 2 February 2018

Extensive soft-tissue involvement by plasmablastic myeloma arising from displaced humeral fractures

scientific article published on November 2010

Extramedullary multiple myeloma escapes the effect of thalidomide.

scientific article published in July 2004

Fingertip cellulitis after fingerstick for capillary microhematocrit measurement in a patient with chronic lymphocytic leukemia: an uncommom infectious complication

scientific article published on 01 December 2002

Generalized cutis laxa and fibrillar glomerulopathy resulting from IgG Deposition in IgG-lambda Monoclonal Gammopathy: pulmonary hemorrhage during stem cell mobilization and complete hematological response with bortezomib and dexamethasone therapy.

scientific article published on 5 November 2008

Hematopoietic stem cell transplantation for multiple myeloma beyond 2010.

scientific article published on 04 March 2010

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

scientific article published on 29 November 2011

How to Treat Multiple Myeloma: Thoughts on a Multicentre Survey in Germany ⬇️

scientific article published on October 25, 2010

Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation

scientific article published on 26 April 2012

Impact of global and gene-specific DNA methylation pattern in relapsed multiple myeloma patients treated with bortezomib.

scientific article published on 8 February 2013

Impact of response to treatment in health-related quality of life patient-reported outcomes in elderly patients with relapsed multiple myeloma

scientific article published on 15 September 2020

Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide

scientific article published on 23 March 2011

Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis

scientific article published on 21 January 2019

Increased serum tumor markers (CA125 and CA15.3) in primary plasma cell leukemia: a case report and review of the literature

scientific article

Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation

scientific article published on 29 April 2018

M-protein-related disorders: MGCS

scientific article published on 01 October 2018

Multiple Myeloma in Serologic Complete Remission after Autologous Stem Cell Transplantation: Impact of Bone Marrow Plasma Cell Assessment by Conventional Morphology on Disease Progression

Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution

scientific article published on 03 May 2013

Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma

scientific article published on 08 June 2020

New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation

scientific article

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

scientific article

Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma.

scientific article

Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma

scientific article published on 25 February 2019

Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution

scientific article published on 27 February 2016

Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis.

scientific article

Pulmonary tumor thrombotic microangiopathy: report of 3 cases and review of the literature

scientific article

Renal outcomes of autologous stem cell transplantation among patients with light-chain amyloidosis: a single centre Spanish experience.

scientific article

Response to thalidomide in multiple myeloma: impact of angiogenic factors

scientific article

Six-2 glomerular expression for the prediction of renal outcome in systemic amyloidosis

scientific article published on 01 January 2019

Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach ⬇️

scientific article published on 06 September 2011

Spontaneous rupture of the spleen as immediate complication in autologous transplantation for primary systemic amyloidosis

scientific article published on 01 January 2008

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study ⬇️

scientific article published on July 12, 2012

Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways.

scientific article

The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever

scientific article published on 04 November 2020

Treatment of Relapsed Myeloma in a Patient With Renal Insufficiency

scientific article published on 31 May 2018

Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature

scientific article published on 28 February 2020

[Autologous haematopoietic stem cell transplantation in POEMS syndrome: results in 4 cases]

scientific article published on 01 October 2007

[Respiratory failure caused by amyloid myopathy]

scientific article published on 28 October 2015

List of works by Maria Teresa Cibeira

A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma.

Abnormal serum free light chain ratio in patients with multiple myeloma in complete remission has strong association with the presence of oligoclonal bands: implications for stringent complete remission definition

Acquired Fanconi syndrome secondary to monoclonal gammopathies: a case series from a single center

Bone marrow angiogenesis and angiogenic factors in multiple myeloma treated with novel agents

Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome.

Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis

Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple m

Bortezomib-induced severe hepatitis in multiple myeloma: a case report

Bortezomib: an effective agent in extramedullary disease in multiple myeloma

Challenges in the Management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic

Dermatomyositis associated with acute myeloid leukaemia: a paraneoplastic association or a drug-induced phenomenon?

Efficacy, safety and quality-of-life associated with lenalidomide plus dexamethasone for the treatment of relapsed or refractory multiple myeloma: the Spanish experience

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression

Extensive soft-tissue involvement by plasmablastic myeloma arising from displaced humeral fractures

Extramedullary multiple myeloma escapes the effect of thalidomide.

Fingertip cellulitis after fingerstick for capillary microhematocrit measurement in a patient with chronic lymphocytic leukemia: an uncommom infectious complication

Generalized cutis laxa and fibrillar glomerulopathy resulting from IgG Deposition in IgG-lambda Monoclonal Gammopathy: pulmonary hemorrhage during stem cell mobilization and complete hematological response with bortezomib and dexamethasone therapy.

Hematopoietic stem cell transplantation for multiple myeloma beyond 2010.

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

How to Treat Multiple Myeloma: Thoughts on a Multicentre Survey in Germany ⬇️

Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation

Impact of global and gene-specific DNA methylation pattern in relapsed multiple myeloma patients treated with bortezomib.

Impact of response to treatment in health-related quality of life patient-reported outcomes in elderly patients with relapsed multiple myeloma

Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide

Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis

Increased serum tumor markers (CA125 and CA15.3) in primary plasma cell leukemia: a case report and review of the literature

Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation

M-protein-related disorders: MGCS

Multiple Myeloma in Serologic Complete Remission after Autologous Stem Cell Transplantation: Impact of Bone Marrow Plasma Cell Assessment by Conventional Morphology on Disease Progression

Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution

Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma

New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dose melphalan and autologous stem-cell transplantation

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma.

Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma

Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution

Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis.

Pulmonary tumor thrombotic microangiopathy: report of 3 cases and review of the literature

Renal outcomes of autologous stem cell transplantation among patients with light-chain amyloidosis: a single centre Spanish experience.

Response to thalidomide in multiple myeloma: impact of angiogenic factors

Six-2 glomerular expression for the prediction of renal outcome in systemic amyloidosis

Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach ⬇️

Spontaneous rupture of the spleen as immediate complication in autologous transplantation for primary systemic amyloidosis

Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study ⬇️

Thalidomide decreases gelatinase production by malignant B lymphoid cell lines through disruption of multiple integrin-mediated signaling pathways.

The avoidance of G-CSF and the addition of prophylactic corticosteroids after autologous stem cell transplantation for multiple myeloma patients appeal for the at-home setting to reduce readmission for neutropenic fever

Treatment of Relapsed Myeloma in a Patient With Renal Insufficiency

Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature

[Autologous haematopoietic stem cell transplantation in POEMS syndrome: results in 4 cases]

[Respiratory failure caused by amyloid myopathy]